Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10810988rdf:typepubmed:Citationlld:pubmed
pubmed-article:10810988lifeskim:mentionsumls-concept:C0012984lld:lifeskim
pubmed-article:10810988lifeskim:mentionsumls-concept:C1458155lld:lifeskim
pubmed-article:10810988lifeskim:mentionsumls-concept:C0665341lld:lifeskim
pubmed-article:10810988lifeskim:mentionsumls-concept:C1511790lld:lifeskim
pubmed-article:10810988lifeskim:mentionsumls-concept:C0004083lld:lifeskim
pubmed-article:10810988lifeskim:mentionsumls-concept:C1521733lld:lifeskim
pubmed-article:10810988lifeskim:mentionsumls-concept:C0237881lld:lifeskim
pubmed-article:10810988lifeskim:mentionsumls-concept:C0220901lld:lifeskim
pubmed-article:10810988lifeskim:mentionsumls-concept:C0205210lld:lifeskim
pubmed-article:10810988lifeskim:mentionsumls-concept:C0750502lld:lifeskim
pubmed-article:10810988pubmed:issue3lld:pubmed
pubmed-article:10810988pubmed:dateCreated2000-7-19lld:pubmed
pubmed-article:10810988pubmed:abstractTextEighty-nine canine mammary tumors and dysplasias of 66 bitches were investigated to determine the immunohistochemical expression of classical estrogen receptor (ER-alpha) and its clinical and pathologic associations and prognostic value. A complete clinical examination was performed and reproductive history was evaluated. After surgery, all animals were followed-up for 18 months, with clinical examinations every 3-4 months. ER-alpha expression was higher in tumors of genitally intact and young bitches (P < 0.01, P < 0.01) and in animals with regular estrous periods (P = 0.03). Malignant tumors of the bitches with a previous clinical history of pseudopregnancy expressed significantly more ER-alpha (P = 0.04). Immunoexpression of ER-alpha decreased significantly with tumor size (P = 0.05) and skin ulceration (P = 0.01). Low levels of ER-alpha were significantly associated with lymph node involvement (P < 0.01). Malignant tumors had lower ER-alpha expression than did benign tumors (P < 0.01). Proliferation index measured by proliferating cell nuclear antigen immunostaining was inversely correlated with ER-alpha scores (P = 0.05) in all tumors. Low ER-alpha levels in primary malignant tumors were significantly associated with the occurrence of metastases in the follow-up (P = 0.03). Multivariate analyses were performed to determine the prognostic significance of some follow-up variables. ER-alpha value, Ki-67 index, and age were independent factors that could predict disease-free survival. Lymph node status, age, and ER-alpha index were independent prognostic factors for the overall survival. The immunohistochemical detection of ER-alpha in canine mammary tumors is a simple technique with prognostic value that could be useful in selecting appropriate hormonal therapy.lld:pubmed
pubmed-article:10810988pubmed:languageenglld:pubmed
pubmed-article:10810988pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10810988pubmed:citationSubsetIMlld:pubmed
pubmed-article:10810988pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10810988pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10810988pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10810988pubmed:statusMEDLINElld:pubmed
pubmed-article:10810988pubmed:monthMaylld:pubmed
pubmed-article:10810988pubmed:issn0300-9858lld:pubmed
pubmed-article:10810988pubmed:authorpubmed-author:NietoAAlld:pubmed
pubmed-article:10810988pubmed:authorpubmed-author:PeñaLLlld:pubmed
pubmed-article:10810988pubmed:authorpubmed-author:CastañoMMlld:pubmed
pubmed-article:10810988pubmed:authorpubmed-author:SánchezM AMAlld:pubmed
pubmed-article:10810988pubmed:authorpubmed-author:FloresJ MJMlld:pubmed
pubmed-article:10810988pubmed:authorpubmed-author:Pérez-AlenzaM...lld:pubmed
pubmed-article:10810988pubmed:issnTypePrintlld:pubmed
pubmed-article:10810988pubmed:volume37lld:pubmed
pubmed-article:10810988pubmed:ownerNLMlld:pubmed
pubmed-article:10810988pubmed:authorsCompleteYlld:pubmed
pubmed-article:10810988pubmed:pagination239-47lld:pubmed
pubmed-article:10810988pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:10810988pubmed:meshHeadingpubmed-meshheading:10810988...lld:pubmed
pubmed-article:10810988pubmed:meshHeadingpubmed-meshheading:10810988...lld:pubmed
pubmed-article:10810988pubmed:meshHeadingpubmed-meshheading:10810988...lld:pubmed
pubmed-article:10810988pubmed:meshHeadingpubmed-meshheading:10810988...lld:pubmed
pubmed-article:10810988pubmed:meshHeadingpubmed-meshheading:10810988...lld:pubmed
pubmed-article:10810988pubmed:meshHeadingpubmed-meshheading:10810988...lld:pubmed
pubmed-article:10810988pubmed:meshHeadingpubmed-meshheading:10810988...lld:pubmed
pubmed-article:10810988pubmed:meshHeadingpubmed-meshheading:10810988...lld:pubmed
pubmed-article:10810988pubmed:meshHeadingpubmed-meshheading:10810988...lld:pubmed
pubmed-article:10810988pubmed:meshHeadingpubmed-meshheading:10810988...lld:pubmed
pubmed-article:10810988pubmed:meshHeadingpubmed-meshheading:10810988...lld:pubmed
pubmed-article:10810988pubmed:year2000lld:pubmed
pubmed-article:10810988pubmed:articleTitleImmunohistologic detection of estrogen receptor alpha in canine mammary tumors: clinical and pathologic associations and prognostic significance.lld:pubmed
pubmed-article:10810988pubmed:affiliationDepartment of Animal Pathology II, Veterinary School, Universidad Complutense de Madrid, Spain. ananieto@eucmax.sim.ucm.eslld:pubmed
pubmed-article:10810988pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10810988pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10810988lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10810988lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10810988lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10810988lld:pubmed